Impaired modulation of sympathetic vasoconstriction in contracting skeletal muscle of rats with chronic myocardial infarctions: Role of oxidative stress

Circulation Research

Volumn 88, Issue 8, 2001, Pages 816-823

  Thomas, Gail D ^a,b   Zhang, Weiguo ^a   Victor, Ronald G ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Heart failure; Nitric oxide; Oxidant stress; Skeletal muscle; Vasoconstriction

Indexed keywords

ARGININE; MALONALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CHRONIC DISEASE; CONDUCTANCE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME INHIBITION; EXERCISE; FEMALE; FEMORAL ARTERY FLOW; HEART FAILURE; HEART INFARCTION; HINDLIMB; MUSCLE CONTRACTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYMPATHETIC NERVE; SYMPATHETIC TONE; VASOCONSTRICTION;

EID: 0035957626     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh0801.089341     Document Type: Article

References (45)

1. Hansen J, Thomas GD, Jocobsen TN, Victor RG. Muscle metaboreflex triggers parallel sympathetic activation in exercising and resting human skeletal muscle. Am J Physiol. 1994;266:H2508-H2514.
2. 2adrenoceptor constriction to metabolic inhibition during rat skeletal muscle contraction. Circ Res. 1991;69:174-184.
3. Thomas GD, Victor RG. Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Physiol (Lond). 1998;506:817-826.
4. Thomas GD, Sander M, Lau KS, Huang PL, Stull JT, Victor RG. Impaired metabolic modulation of α-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci U S A. 1998;95: 15090-15095.
5. Sander M, Chavoshan B, Harris SA, Iannaccone ST, Stull JT, Thomas GD, Victor RG. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A. 2000;97:13818-13823.
6. Kobzik L, Reid MB, Bredt DS, Stamler JS. Nitric oxide in skeletal muscle. Nature. 1994;372:546-548.
7. Kobzik L, Stringer B, Balligand J-L, Reid MB, Stamler JS. Endothelial type nitric oxide synthase in skeletal muscle fibers: mitochondrial relationships. Biochem Biophys Res Commun. 1995;211:375-381.
8. Chang WJ, Iannaccone ST, Lau KS, Masters BSS, McCabe TJ, McMillan K, Padre RC, Spencer MJ, Tidball JG, Stull JT. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci U S A. 1996;93:9142-9147.
9. Didion SP, Carmines PK, Ikenaga H, Mayhan WG. Enhanced constrictor responses of skeletal muscle arterioles during chronic myocardial infarction. Am J Physiol. 1997;273:H1502-H1508.
10. Gaballa MA, Goldman S. Overexpression of endothelium nitric oxide synthase reverses the diminished vasorelaxation in the hindlimb vasculature in ischemic heart failure in vivo. J Mol Cell Cardiol. 1999;31: 1243-1252.
11. Teerlink JR, Gray GA, Clozel M, Clozel J-P. Increased vascular responsiveness to norepinephrine in rats with heart failure is endothelium dependent. Dissociation of basal and stimulated nitric oxide release. Circulation. 1994;89:393-401.
12. Katz SD, Khan T, Zeballos GA, Mathew L, Potharlanka P, Knecht M, Whelan J. Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure. Circulation. 1999;99: 2113-2117.
13. Hirai T, Zelis R, Musch TI. Effects of nitric oxide synthase inhibition on the muscle blood flow response to exercise in rats with heart failure. Cardiovasc Res. 1995;30:469-476.
14. Katz SD, Krum H, Khan T, Knecht M. Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. J Am Coll Cardiol. 1996;28:585-590.
15. Comini L, Bachetti T, Gaia G, Pasini E, Agnoletti L, Pepi P, Ceconi C, Curello S, Ferrari R. Aorta and skeletal muscle NO synthase expression in experimental heart failure. J Mol Cell Cardiol. 1996; 28:2241-2248.
16. Bauersachs J, Bouloumié A, Fraccarollo D, Hu K, Busse R, Ertl G. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression. Role of enhanced vascular superoxide production. Circulation. 1999;100:292-298.
17. Ide T, Tsutsui H, Kinugawa S, Suematsu N, Hayashidani S, Ichikawa K, Utsumi H, Machida Y, Egashira K, Takeshita A. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res. 2000;86:152-157.
18. Díaz-Vélez CR, García-Castiñeiras S, Mendoza-Ramos E, Hernández-López E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am Heart J. 1996;131:146-152.
19. Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, Jeejeebhoy KN. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol. 1998;31:1352-1356.
20. Nishiyama Y, Ikeda H, Haramaki N, Yoshida N, Imaizumi T. Oxidative stress is related to exercise intolerance in patients with heart failure. Am Heart J. 1998;135:115-120.
21. Chien YW, Barbee RW, MacPhee AA, Frohlich ED, Trippodo NC. Increased ANF secretion after volume expansion is preserved in rats with heart failure. Am J Physiol. 1988;254:R185-R191.
22. Lau KS, Grange RW, Chang W-J, Kamm KE, Sarelius I, Stull JT. Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide. FEBS Lett. 1998;431:71-74.
23. Hill MF, Singal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation. 1997;96:2414-2420.
24. Reid MB, Haack KE, Franchek KM, Valberg PA, Kobzik L, West MS. Reactive oxygen in skeletal muscle, I: intracellular oxidant kinetics and fatigue in vitro. J Appl Physiol. 1992;73:1797-1804.
25. Jenkins RR, Krause K, Schofield LS. Influence of exercise on clearance of oxidant stress products and loosely bound iron. Med Sci Sports Exerc. 1993;25:213-217.
26. Liu J, Yeo HC, Övervik-Douki E, Hagen T, Doniger SJ, Chu DW, Brooks GA, Ames BN. Chronically and acutely exercised rats: biomarkers of oxidative stress and endogenous antioxidants. J Appl Physiol. 2000;89: 21-28.
27. Kojda G, Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res. 1999;43:562-571.
28. Simonini A, Long CS, Dudley GA, Yue P, McElhinny J, Massie BM. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circ Res. 1996;79:128-136.
29. Ide T, Tsutsui H, Kinugawa S, Utsumi H, Kang D, Hattori N, Uchida K, Egashira K, Takeshita A. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res. 1999;85:357-363.
30. Varin R, Mulder P, Richard V, Tamion F, Devaux C, Henry J-P, Lallemand F, Lerebours G, Thuillez C. Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure. Role of nitric oxide, prostanoids, and oxidant stress. Circulation. 1999; 99:2951-2957.
31. Segal SS, Brett SE, Sessa WC. Codistribution of NOS and caveolin throughout peripheral vasculature and skeletal muscle of hamsters. Am J Physiol. 1999;277:H1167-H1177.
32. Beckman JS, Freeman BA. Antioxidant enzymes as mechanistic probes of oxygen-dependent toxicity. In: Taylor AE, Tatalon S, Ward PA, eds. Physiology of Oxygen Radicals. Bethesda, Md: American Physiological Society; 1986:39-53.
33. Balon TW, Nadler JL. Nitric oxide release is present from incubated skeletal muscle preparations. J Appl Physiol. 1994;77:2519-2521.
34. Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T. Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci. 1998;62:2425-2430.
35. Feng Q, Lu X, Fortin AJ, Pettersson A, Hedner T, Kline RL, Arnold JMO. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure. Cardiovasc Res. 1998;37:667-675.
36. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP. Novel mechanism for endothelial dysfunction. Dysregulation of dimethyl-arginine dimethylaminohydrolase. Circulation. 1999;99:3092-3095.
37. Mülsch A, Bauersachs J, Schafer A, Stasch JP, Kast R, Busse R. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol. 1997;120:681-689.
38. Wascher TC, Posch K, Wallner S, Hermetter A, Kostner GM, Graier WF. Vascular effects of L-arginine: anything beyond a substrate for the NO-synthase? Biochem Biophys Res Commun. 1997;234:35-38.
39. Feng Q, Fortin AJ, Lu X, Malcolm J, Arnold O. Effects of L-arginine on endothelial and cardiac function in rats with heart failure. Eur J Pharmacol. 1999;376:37-44.
40. Hanssen H, Brunini TMC, Conway M, Banning AP, Roberts NB, Mann GE, Ellory JC, Mendes Ribeiro AC. Increased L-arginine transport in human erythrocytes in chronic heart failure. Clin Sci. 1997;94:43-48.
41. Pou S, Pou WS, Bredt DS, Snyder SH, Rosen CM. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem. 1992; 267:24173-24176.
42. Lang CC, Rayos GH, Chomsky DB, Wood AJJ, Wilson JR. Effect of sympathoinhibition on exercise performance in patients with heart failure. Circulation. 1997;96:238-245.
43. Shoemaker JK, Naylor HL, Hogeman CS, Sinoway LI. Blood flow dynamics in heart failure. Circulation. 1999;99:3002-3008.
44. Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation. 1989;80:769-781.
45. Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation. 1984;69:1079-1087.